0001628738-15-000001.txt : 20150902 0001628738-15-000001.hdr.sgml : 20150902 20150901192415 ACCESSION NUMBER: 0001628738-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150902 DATE AS OF CHANGE: 20150901 EFFECTIVENESS DATE: 20150902 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Audentes Therapeutics, Inc. CENTRAL INDEX KEY: 0001628738 IRS NUMBER: 461606174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-246838 FILM NUMBER: 151088338 BUSINESS ADDRESS: STREET 1: 101 MONTGOMERY STREET, SUITE 2650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 415-638-6556 MAIL ADDRESS: STREET 1: 101 MONTGOMERY STREET, SUITE 2650 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 D 1 primary_doc.xml X0707 D LIVE 0001628738 Audentes Therapeutics, Inc. 101 MONTGOMERY STREET, SUITE 2650 SAN FRANCISCO CA CALIFORNIA 94104 415-638-6556 DELAWARE None None Corporation true 2012 Matthew Patterson 101 Montgomery St., Suite 2650 San Francisco CA CALIFORNIA 94104 Executive Officer Director Jonathan Silverstein OrbiMed Advisors, LLC 601 Lexington Ave., 54th Floor New York NY NEW YORK 10022 Director Kush Parmar 5AM Ventures 2200 Sand Hill Rd., Suite 110 Menlo Park CA CALIFORNIA 94025 Director Thomas Woiwode Versant Ventures One Sansome St., Suite 3630 San Francisco CA CALIFORNIA 94104 Director Thomas Schuetz 101 Montgomery St., Suite 2650 San Francisco CA CALIFORNIA 94104 Director Jonathan Leff Deerfield Management 780 Third St., 37th Floor New York NY NEW YORK 10017 Director Steve Squinto 101 Montgomery St., Suite 2650 San Francisco CA CALIFORNIA 94104 Director Louis G. Lange 101 Montgomery St., Suite 2650 San Francisco CA CALIFORNIA 94104 Director Biotechnology Decline to Disclose 06b false 2015-08-17 false true true 0 Indefinite 0 Indefinite false 21 0 0 0 false Audentes Therapeutics, Inc. Matthew Patterson Matthew Patterson President and CEO 2015-09-01